1.Tao Yu*, Yingjun Zhao*, Zhixiang Hu, Jing Li, Dandan Chu1 Jiwei Zhang, Zhe Li, Bing Chen, Xiao Zhang, Hongyu Pan, Shengli Li, Hechun Lin, Lei Liu, Mingxia Yan, Xianghuo He†, and Ming Yao†. MetaLnc9 Facilitates Lung Cancer Metastasis via a PGK1-Activated AKT/mTOR Pathway. Cancer Research. 2017 Nov 1;77(21):5782-5794. doi: 10.1158/0008-5472.CAN-17-0671. (IF=9.619)

2.Jiwei Zhang*, Zhe Li*, Longzi Liu*, Qifeng Wang, Shengli Li, Di Chen, Zhixiang Hu, Tao Yu, Jie Ding, Jinjun Li, Ming Yao, Shenglin Huang, Yingjun Zhao†, Xianghuo He1†. Long Noncoding RNA TSLNC8 Is a Tumor Suppressor that Inactivates the IL-6/STAT3 Signaling Pathway. Hepatology. 2017 Jul 26. doi: 10.1002/hep.29405. [Epub ahead of print] (IF=13.246)

3.Qiu Zhaoping*, Guo Weijie*, Wang Qifeng*, Chen Zhiao, Huang Shenglin, Zhao Fangyu, Yao Ming, Zhao Yingjun†, He Xianghuo†. MicroRNA-124 reduces the pentose phosphate pathway and proliferation by targeting PRPS1 and RPIA mRNAs in human colorectal cancer cells. Gastroenterology, 2015, 149(6):1587-1598.e11. (IF=16.716)

4.Guo Weijie*, Qiu Zhaoping*, Wang Zhichao*, Wang Qifeng, Tan Ning, Chen Taoyang, Chen Zhiao, Huang Shenglin, Gu Jianren, Li Jinjun, Yao Ming, Zhao Yingjun†, He Xianghuo†. MiR-199a-5p is negatively associated with malignancies and regulates glycolysis and lactate production by targeting hexokinase 2 in liver cancer. Hepatology, 2015, 62(4):1132-1144. (IF=11.055)

5.Chen Di*, Guo Weijie*, Qiu Zhaoping, Wang Qifeng, Li Yan, Liang Linhui, Liu Li, Huang Shenglin, Zhao Yingjun†, He Xianghuo†. MicroRNA-30d-5p inhibits tumour cell proliferation and motility by directly targeting CCNE2 in non-small cell lung cancer. Cancer Letters, 2015, 362(2): 208-217. (IF=5.621)

6.Gao Qiang*, Zhao Ying-Jun*, Wang Xiao-Ying*, Guo Wei-Jie, Gao Song, Wei Lin, Shi Jie-Yi, Shi Guo-Ming, Wang Zhi-Chao, Zhang Yuan-Nv, Shi Ying-Hong, Ding Jie, Ding Zhen-Bin, Ke Ai-Wu, Dai Zhi, Wu Fei-Zhen, Wang Hui, Qiu Zhao-Ping, Chen Zhi-Ao, Zhang Zhen-Feng, Qiu Shuang-Jian, Zhou Jian†, He Xiang-Huo†, Fan Jia†. Activating mutations in PTPN3 promote cholangiocarcinoma cell proliferation and migration and are associated with tumor recurrence in patients. Gastroenterology, 2014, 146(5):1397-1407. (IF=13.926)

7.Gao Qiang*, Zhao Ying-Jun*, Wang Xiao-Ying, Qiu Shuang-Jian, Shi Ying-Hong, Sun Jian, Yi Yong, Shi Jie-Yi, Shi Guo-Ming, Ding Zhen-Bin, Xiao Yong-Sheng, Zhao Zhong-Hua, Zhou Jian, He Xiang-Huo†, Fan Jia†. CXCR6 upregulation contributes to a pro-inflammatory tumor microenvironment that drives metastasis and poor patient outcomes in hepatocellular carcinoma. Cancer Research, 2012, 72(14):3546-56. (IF=8.65)

8.Yingjun Zhao*, Xiaoying Wang*, Tao Wang, Xin Hu, Xin Hui, Mingxia Yan, Qiang Gao, Taoyang Chen, Jinjun Li, Ming Yao, Dafang Wan, Jianren Gu†, Jia Fan† and Xianghuo He†. Acetylcholinesterase, a Key Prognostic Predictor for Hepatocellular Carcinoma, Suppresses Cell Growth and Induces Chemosensitization. Hepatology, 2011, 53(2):493-503. (IF=10.88)

9.Weijie Guo*, Yingjun Zhao*, Zhenfeng Zhang, Ning Tan, Fangyu Zhao, Chao Ge, Linhui Liang, Deshui Jia, Taoyang Chen, Ming Yao, Jinjun Li, Xianghuo He†. Disruption of xCT inhibits cell growth via the ROS/autophagy pathway in hepatocellular carcinoma. Cancer Letters, 2011, 312: 55-61. (IF=4.86)

10.Xin Hu*, Yingjun Zhao*, Xianghuo He, Jinjun Li, Tao Wang, Weiping Zhou, Dafang Wan, Hongyang Wang, Jianren Gu. Ciliary Neurotrophic Factor Receptor α Subunit–Modulated Multiple Downstream Signaling Pathways in Hepatic Cancer Cell Lines and Their Biological Implications. Hepatology, 2008, 47(4):1298-308. (IF=10.73)